Dogs with brain tumors live a median of about 2 months with palliative care alone, and roughly 17 to 23 months with active treatment like radiation therapy. The range is wide because survival depends heavily on tumor type, location, and which treatments you pursue. Understanding these timelines can help you make informed decisions about your dog’s care.
Survival With Palliative Care Only
If treatment is limited to comfort measures like steroids to reduce brain swelling and anticonvulsants to control seizures, the prognosis is unfortunately short. The median survival time for dogs with primary brain tumors receiving only palliative care is about 69 days, with most studies reporting a range of 30 to 90 days. Some dogs live longer, but the majority decline within a few months.
For dogs with gliomas (tumors arising from the brain’s supporting tissue) managed with only symptomatic care, the median drops further to roughly 35 days. Palliative care can meaningfully improve comfort during this window, but it does not slow tumor growth.
How Treatment Changes the Timeline
Active treatment can extend survival significantly. The three main options are radiation therapy, surgery, and chemotherapy, and each carries different expectations.
Radiation Therapy
Radiation is the treatment most consistently linked to longer survival. In a large study of 285 dogs with suspected meningiomas (the most common brain tumor type), dogs treated with radiation had a median survival of 696 days, just under two years. A quarter of those dogs lived beyond 999 days, nearly three years.
For dogs with either meningiomas or gliomas treated with radiation, median survival was about 524 days (roughly 17 months). Meningiomas responded slightly better at 536 days compared to 512 days for gliomas, though the difference was modest.
Pituitary tumors, which grow from the hormone-producing gland at the base of the brain, also respond well to radiation. Reported median survival after irradiation ranges from about 12 to 25 months. In one group of dogs whose pituitary tumors eventually caused worsening neurological problems, the median survival was still 43.6 months, over three and a half years.
Surgery
Surgical removal is sometimes possible depending on where the tumor sits. For meningiomas, which tend to grow on the brain’s surface rather than within it, surgery produced a median survival of 297 days (about 10 months). That’s notably shorter than radiation’s 696 days for the same tumor type. Counterfactual modeling, which attempts to account for differences between the two groups, still estimated a 29% survival advantage for radiation over surgery.
Surgery does offer some dogs excellent outcomes. A quarter of surgically treated dogs in that study lived beyond 768 days. But the lower end was also more concerning: a quarter survived fewer than 99 days, likely reflecting cases where tumors couldn’t be fully removed or complications arose.
Chemotherapy
Chemotherapy is often considered when radiation or surgery isn’t feasible, whether due to tumor location, cost, or the dog’s overall health. For dogs with presumed gliomas, one chemotherapy drug extended median survival to 138 days compared to 35 days with symptomatic care alone. That’s a meaningful improvement, nearly quadrupling survival time, though still considerably shorter than what radiation typically achieves.
Side effects are common with chemotherapy. In one study, 46% of treated dogs developed low white blood cell counts, and about half showed signs of liver stress on bloodwork. These side effects are manageable in many cases but require regular monitoring.
Tumor Type Matters
The two most common brain tumors in dogs are meningiomas and gliomas. Meningiomas grow from the membranes surrounding the brain and tend to be more accessible for treatment. They generally carry a somewhat better prognosis. Gliomas grow from within the brain tissue itself and are harder to target surgically, though they still respond to radiation.
Certain breeds are predisposed to specific tumor types. Brachycephalic breeds (short-nosed dogs like Boxers, Boston Terriers, and Bulldogs) develop gliomas more frequently. Longer-nosed breeds like Golden Retrievers and German Shepherds are more prone to meningiomas. Brain tumors overall are most commonly diagnosed in dogs over 5 years old, with the highest incidence in middle-aged to older dogs.
Pituitary tumors behave differently from both meningiomas and gliomas. They often cause hormonal problems (like Cushing’s disease) before any neurological signs appear, which sometimes means they’re caught earlier. Their response to radiation tends to be favorable.
What Symptoms Look Like Over Time
The signs you’ll notice depend on where the tumor is located in the brain. Seizures are the most common first symptom, especially in dogs that have never had seizures before. Other early signs include changes in behavior or personality, walking in circles, head tilting, vision problems, and general confusion or disorientation.
As the tumor grows, symptoms typically worsen. You may see increasing difficulty walking, loss of coordination, changes in appetite, and the dog becoming less responsive or aware of its surroundings. In advanced stages, progression can lead to paralysis, coma, and death. The speed of this progression varies. Some dogs decline over weeks, others over many months, particularly with treatment slowing tumor growth.
Evaluating Your Dog’s Quality of Life
Survival time in days or months only tells part of the story. What most owners really want to know is whether their dog is comfortable and still enjoying life. Veterinarians often recommend evaluating quality of life across several categories: pain levels, ability to eat and drink independently, hygiene (including bladder and bowel control), happiness and responsiveness, and mobility.
The core question to revisit regularly is whether your dog has more good days than bad. A good day means your dog is comfortable, interested in its surroundings, eating willingly, and able to move around. A bad day involves noticeable pain, refusal to eat, inability to stand or walk, or seeming disconnected from the family. When bad days begin to outnumber good ones consistently, that shift is a meaningful signal regardless of what the survival statistics suggest.
Keeping a simple daily log of how your dog is doing can help you spot trends that are hard to notice in the moment. It also gives you concrete information to share with your veterinarian when making decisions about continuing, adjusting, or stopping treatment.
Putting the Numbers in Perspective
Survival statistics are medians, meaning half of dogs lived longer and half lived shorter than the reported number. Your dog’s outcome depends on factors no study can fully capture: the tumor’s exact size and position, how early it was caught, your dog’s overall health, and how it responds to treatment individually.
The practical takeaway is that the gap between no treatment (roughly 1 to 3 months) and active treatment (roughly 10 to 23 months depending on approach) is substantial. Even chemotherapy alone, the least aggressive active option, nearly quadrupled survival compared to palliative care in dogs with gliomas. For owners weighing whether treatment is worth pursuing, that difference is real, though it needs to be balanced against the dog’s comfort, the intensity of the treatment protocol, and what your family can manage.